Intelligent Bio Solutions Inc
Company Profile
Business description
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Contact
135 West, 41ST Street
5th Floor
New YorkNY10036
USAT: +1 646 828-8258
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
55
Stocks News & Analysis
stocks
Chart of the Week: AI proving a threat to company moats
stocks
ASX coal miners will benefit from higher prices
stocks
Nvidia earnings: Another stellar quarter with no signs of a slowdown
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,699.70 | 12.10 | -0.14% |
| CAC 40 | 7,969.88 | 4.61 | -0.06% |
| DAX 40 | 23,502.25 | 228.67 | -0.96% |
| Dow JONES (US) | 46,199.62 | 793.64 | -1.69% |
| FTSE 100 | 10,305.29 | 98.31 | -0.94% |
| HKSE | 25,593.03 | 432.39 | -1.66% |
| NASDAQ | 22,164.37 | 315.16 | -1.40% |
| Nikkei 225 | 53,655.75 | 1,583.65 | -2.87% |
| NZX 50 Index | 13,070.50 | 111.73 | -0.85% |
| S&P 500 | 6,626.82 | 89.27 | -1.33% |
| S&P/ASX 200 | 8,507.00 | 1.60 | 0.02% |
| SSE Composite Index | 4,024.23 | 38.75 | -0.95% |